A COMPARISON OF THE PROGNOSTIC VALUE OF EARLY PSA TEST-BASED VARIABLES FOLLOWING EXTERNAL BEAM RADIOTHERAPY, WITH OR WITHOUT PRECEDING ANDROGEN DEPRIVATION: ANALYSIS OF DATA FROM THE TROG 96.01 RANDOMIZED TRIAL
David S Lamb, James W Denham, David Joseph, John Matthews, Chris Atkinson, Nigel A Spry, Gillian Duchesne, Martin Ebert, Allison Steigler, Brett Delahunt, Catherine D'Este
International Journal of Radiation Oncology*Biology*Physics | ELSEVIER SCIENCE INC | Published : 2011
Awarded by Australian Government National Health and Medical Research Council
This work was funded by the Australian Government National Health and Medical Research Council (project grant applications 9936572, 209801, and 455520); the Hunter Medical Research Institute (Newcastle, Australia); AstraZeneca Pty. Ltd. (Sydney, Australia); and Schering-Plough Pty. Ltd., Sydney, Australia.Allison Steigler and David Lamb received support from AstraZeneca to attend one or more meetings; John Matthews received support from AstraZeneca and Schering Plough to attend an Australasian meeting; David Joseph received honoraria associated with membership of AstraZeneca's Breast Cancer Medical Advisory Board; Gillian Duchesne received a travel grant from AstraZeneca to attend a European prostate cancer symposium in 2006; and Nigel Spry received honoraria associated with AstraZeneca and Schering Plough and research funding from Schering Plough.